· Periodic Report
Q3 profit from main business KRW 2.0 billion on sales of KRW 14.8 billion
Cell Biotech sold KRW 14.8 billion worth in Q3 and earned KRW 2.0 billion from its main business, down 9.4% from a year earlier.
049960 · KOSDAQ · Based on DART filings
2 total · 20 per page
· Periodic Report
Cell Biotech sold KRW 14.8 billion worth in Q3 and earned KRW 2.0 billion from its main business, down 9.4% from a year earlier.
· Preliminary Earnings
Q3 consolidated revenue was KRW 14.8 billion, down 3.3% YoY and 6.1% QoQ, with operating profit of KRW 2.0 billion, down 9.4% YoY and up 22.4% QoQ.
Get app alerts for new disclosures from CELL BIOTECH CO ., LTD.